Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 6, 2011
Distillery Therapeutics

Indication: Autoimmune disease

BioCentury | Oct 3, 2005
Clinical News

Intranasal PTH 1-34: Phase I data

BioCentury | Oct 3, 2005
Clinical News

Preos: Additional Phase II data

BioCentury | Oct 3, 2005
Clinical News

Preos: Additional Phase III data

BioCentury | Aug 15, 2005
Clinical News

Forteo teriparatide: Post-marketing study data

BioCentury | Aug 15, 2005
Clinical News

Preos musculoskeletal data

BioCentury | Jul 11, 2005
Clinical News

Intranasal PTH 1-34: Phase I started

BioCentury | Apr 11, 2005
Clinical News

Preos: Phase III additional data

BioCentury | Oct 18, 2004
Clinical News

Parathyroid hormone: Phase I preliminary data

BioCentury | Oct 11, 2004
Clinical News

Preos: Phase III data

Items per page:
1 - 10 of 16
Help Center
Username
Request a Demo
Request Training
Ask a Question